CLEC2D and glioblastoma: Glioblastomas efficiently reprogram their microenvironment towards an immunosuppressive milieu [7] by altered surface molecule expressions, e.g., human leucocyte antigen (HLA)-E and lectin-like transcript-1 (LLT-1) [8,9].